This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Berger P, Hillman M, Tabak M, Vollrath M (1991) The lymphocyte transformation test with type II collagen as a diagnostic tool of autoimmune sensorineural hearing loss. Laryngoscope 101:895–899.
Bieckert P (1961) On the problem of perception deafness and autoallergy. Z Laryngol Rhinol Otol 40:837–842.
Broughton SS, Meyerhoff WE, Cohen SB (2004) Immune-mediated inner ear disease: 10-year experience. Semin Arthritis Rheum 34:544–548.
Clemis JD (1975) Allergy as a cause of fluctuant hearing loss. Otol Clin N Am 8: 375–383.
Fukuda S, Harris JP, Keithley EM, Ishikawa K, Kucuk B, Inuyama Y (1992) Spiral modiolar vein: its importance in viral load of the inner ear. Ann Otol Rhinol Laryngol Suppl 157:67–71.
Harris JP (1983) Immunology of the inner ear: response of the inner ear to antigen challenge. Otolaryngol Head Neck Surg 91:18–32.
Harris JP (1984) Immunology of the inner ear: evidence of local antibody production. Ann Otol Rhinol Laryngol 93:157–162.
Harris JP (1987) Experimental autoimmune sensorineural hearing loss. Laryngoscope 97:63–76.
Harris JP (1989) Autoimmunity of the inner ear. Am J Otol 10:193–195.
Harris JP, Keithley EM (2002) Autoimmune inner ear disease. In Snow JB, Ballenger JJ (eds) Otorhinolaryngology Head and Neck Surgery. Baltimore: BC Decker,pp. 396–407.
Harris JP, Ryan AF (1984) Immunobiology of the inner ear. Am J Otolaryngol 5:418–425.
Harris JP, Fukuda S, Keithley EM (1990) Spiral modiolar vein: its importance in inner ear inflammation. Acta Otolaryngol 110:357–365.
Harris JP, Heydt J, Keithley EM, Chen MC (1997) Immunopathology of the inner ear: an update. Ann NY Acad Sci 830:166–178.
Harris JP, Weisman WH, Derebery JM, Espeland MA, Gantz BJ, Gulya AS,Hammerschlag PE, Hannley M, et al. (2003) Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial. JAMA 290:1875–1883.
Hirose K, Wener MH, Duckert LG (1999) Utility of laboratory testing in autoimmune inner ear disease. Laryngoscope 109:1749–1754.
Hughes GB, Barna BP, Kinney SE, Calabrese LH, Nalepa NJ (1988) Clinical diagnosis of immune inner-ear disease. Laryngoscope 98:251–253.
Lehnhardt E (1958) Sudden hearing disorders occurring simultaneously or successively on both sides. Z Laryngol Rhinol Otol 37:1–16.
Luetje CM, Berliner KI (1997) Plasmapharesis in autoimmune inner ear disease: long-term follow-up. Am J Otol 18:572–576.
Ma C, Billings P, Harris JP, Keithley EM (2000) Characterization of an experimentally induced inner ear immune response. Laryngoscope 110:451–456.
Matteson EL, Choi HK, Poe DS, Wise C, Lowe VJ, McDonald TJ, and Rahman MU (2005) Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study. Arthritis Rheum 53:337–342.
McCabe BF (1979) Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 88:585–589.
Mogi G, Lim DJ, Watanabe N (1982) Immunologic study on the inner ear. Immunoglo- bulins in perilymph. Arch Otolaryngol 108:270–275.
Moscicki RA, San Martin JE, Quintero CH, Rauch SD, Nadol JB Jr, and Bloch KJ. (1994) Serum antibody to inner ear proteins in patients with progressive hearing loss. JAMA 272:611–616.
Nair TS, Prieskorn DM, Miller JM, Mori A, Gray J and Carey TE. (1997) In vivo binding and hearing loss after intracochlear infusion of KHRI-3 antibody. Hear Res 107:93–101.
Nair TS, Kozma KE, Hoefling NL, Kommareddi PK, Ueda Y, Gong TW, Lomax MI, Lansford CD, Telian SA, Satar B, Arts HA, EI-Kashlan HK, Berryhill WE, Raphael Y, Carey TE. (2004) Identification and characterization of choline transporter-like protein 2, an inner ear glycoprotein of 68 and 72 kDa that is the target of antibody-induced hearing loss. J Neurosci 24:1772–1779.
Niparko JK, Wang NY, Rauch SD, Russell GB, Espeland MA, Pierce JJ, Bowditch S, Masuda A, et al. (2005) Serial audiometry in a clinical trial of AIED treatment. Otol Neurotol 26:908–917.
Oppenheim JJ, Shecter B (1980) Lymphocyte transformation. In: Zachary AA, Braun WE (eds) Manual of Clinical Immunology, 2nd ed. Washington, DC: American Society Microbiology, pp. 233–245.
Palva T, Raunio V (1967) Disc electrophoretic studies of human perilymph. Ann Otol Rhinol Laryngol 76:23–36.
Rauch SD (1997) Clinical management of immune-mediated inner-ear disease. Ann NY Acad Sci 830:203–210.
Rocklin RE (1980) Production and assay of macrophage inhibitory factor. In: Zachary AA, Braun WE (eds) Manual of Clinical Immunology, 2nd ed. Washington, DC: American Society Microbiology, pp. 246–251.
Ruckenstein MJ (2004) Autoimmune inner ear disease. Curr Opin Otolaryngol Head Neck Surg 12:426–430.
Ryan AF, Gloddek B, Harris JP (1997) Lymphocyte trafficking to the inner ear. Ann NY Acad Sci 830:236–242.
Ryan AF, Harris JP, Keithley EM (2002) Immune-mediated hearing loss: basic mechanisms and options for therapy. Acta Otolaryngol Suppl 548:38–43.
Satoh H, Firestein GS, Billings PB, Harris JP, Keithley EM (2003) Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation. J Assoc Res Otolaryngol 4:139–147.
Schiff M, Brown M (1974) Hormones and sudden deafness. Laryngoscope 84:1959–1981.
Shin S, Billings P, Keithley E, Harris JP (1997) Comparison of anti-heat shock protein 70 (anti-hsp70) and anti-68-kDa inner ear protein in the sera of patients with Ménière’s disease. Laryngoscope 107:222–227.
Suzuki M, Mogi G, Harris JP (1994) Expression of intercellular adhesion molecule-1 during inner ear inflammation. Ann Otol Rhinol Laryngol 104:69–75.
Takahashi M, Harris JP (1988) Anatomic distribution and localization of immunocompetent cells in normal mouse endolymphatic sac. Acta Otolaryngol 106:409–416.
Takasu T, Harris JP (1997) Reduction of inner ear inflammation by treatment with anti-ICAM-1 antibody. Ann Otol Rhinol Laryngol 106:1070–1075.
Tomiyama S, Harris JP (1986) The endolymphatic sac: its importance in inner ear immune responses. Laryngoscope 96:685–691.
van Wijk F, Staecker H, Keithley E, Lefebvre P (2006) Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss. Audiol Neurootol 11:357–365.
Veldman JE, Roord JJ, O’Connor AF, Shea JJ (1984) Autoimmunity and inner ear disorders: an immune-complex mediated sensorineural hearing loss. Laryngoscope 94:501–507.
Woolf NK, Harris JP, Ryan AF, Butler DM, and Richman DD. (1985) Hearing loss in experimental cytomegalovirus infection of the guinea pig inner ear: prevention by systemic immunity. Ann Otol Rhinol Laryngol 94:350–356.
Yamanobe S, Harris JP, Keithley EM (1993) Evidence of direct communication of bone marrow cells with the endolymphatic sac in experimental autoimmune labyrinthitis. Acta Otolaryngol 113:166–170.
Yoo TJ, Tomoda K, Stuart JM, Cremer MA et al. (1983) Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. Ann Otol Rhinol Laryngol 92:267–271.
Yoshihiko T, Yukihiro S (1964) Studies on experimental allergic (isoimmune) labyrinthitis in guinea pigs. Acta Otolaryngol 58:49–64.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Gopen, Q., Harris, J.P. (2008). Autoimmune Inner Ear Disease. In: Schacht, J., Popper, A.N., Fay, R.R. (eds) Auditory Trauma, Protection, and Repair. Springer Handbook of Auditory Research, vol 31. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-72561-1_5
Download citation
DOI: https://doi.org/10.1007/978-0-387-72561-1_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-72560-4
Online ISBN: 978-0-387-72561-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)